| # | Drug | Count |
|---|---|---|
| 0 | FARICIMAB | 776 |
| 1 | BEVACIZUMAB | 133 |
| 2 | AFLIBERCEPT | 52 |
| 3 | RANIBIZUMAB | 20 |
| 4 | BROLUCIZUMAB | 9 |
| 5 | DEXAMETHASONE | 7 |
| 6 | HYDROXYCHLOROQUINE | 6 |
| 7 | FINGOLIMOD HCL | 5 |
| 8 | HYDROXYCHLOROQUINE SULFATE | 5 |
| 9 | PEGCETACOPLAN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FARICIMAB | 776 | 0.0875 |
| 1 | VON WILLEBRAND FACTOR (RECOMBINANT) | 1 | 0.0032 |
| 2 | TETRACAINE | 1 | 0.0025 |
| 3 | BROLUCIZUMAB | 9 | 0.0025 |
| 4 | PEGCETACOPLAN | 4 | 0.0021 |
| 5 | AFLIBERCEPT | 52 | 0.0017 |
| 6 | BEVACIZUMAB | 133 | 0.0011 |
| 7 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 1 | 0.0009 |
| 8 | RANIBIZUMAB | 20 | 0.0008 |
| 9 | BEVACIZUMAB-AWWB | 2 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 174 | 0.0009 |
| 1 | Antiseptic [EPC] | 1 | 0.0002 |
| 2 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 3 | Complement Inhibitor [EPC] | 4 | 0.0001 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 6 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |